Celularity Enterprise Value Over E B I T D A from 2010 to 2025
| CELU Stock | USD 2.05 0.16 7.24% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.53) | Current Value (0.56) | Quarterly Volatility 1.6 M |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Net Income Applicable To Common Shares of 17.1 M or Income Tax Expense of 12.1 K, as well as many indicators such as Price To Sales Ratio of 2.11, Dividend Yield of 0.0 or PTB Ratio of 1.02. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Enterprise Value Over E B I T D A |
Latest Celularity's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Celularity over the last few years. It is Celularity's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Celularity Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (1,804,313) | |
| Coefficient Of Variation | (91.08) | |
| Mean Deviation | 1,578,754 | |
| Median | (3,207,651) | |
| Standard Deviation | 1,643,420 | |
| Sample Variance | 2.7T | |
| Range | 3.2M | |
| R-Value | 0.86 | |
| Mean Square Error | 748.9B | |
| R-Squared | 0.74 | |
| Significance | 0.000019 | |
| Slope | 297,179 | |
| Total Sum of Squares | 40.5T |
Celularity Enterprise Value Over E B I T D A History
About Celularity Financial Statements
Celularity shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.53) | (0.56) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.